Abstract:Background: In this study, we aimed to develop a new end-to-end learning model called Graph-Drug-Target Interaction (DTI), which integrates various types of information in the heterogeneous network data, and to explore automatic learning of the topology-maintaining representations of drugs and targets, thereby effectively contributing to the prediction of DTI. Precise predictions of DTI can guide drug discovery and development. Most machine learning algorithms integrate multiple data sources and combine them with common embedding methods. However, the relationship between the drugs and target proteins is not well reported. Although some existing studies have used heterogeneous network graphs for DTI prediction, there are many limitations in the neighborhood information between the nodes in the heterogeneous network graphs. We studied the drug-drug interaction (DDI) and DTI from DrugBank Version 3.0, protein-protein interaction (PPI) from the human protein reference database Release 9, drug structure similarity from Morgan fingerprints of radius 2 and calculated by RDKit, and protein sequence similarity from Smith-Waterman score. Methods: Our study consists of three major components. First, various drugs and target proteins were integrated, and a heterogeneous network was established based on a series of data sets. Second, the graph neural networks-inspired graph auto-encoding method was used to extract high-order structural information from the heterogeneous networks, thereby revealing the description of nodes (drugs and proteins) and their topological neighbors. Finally, potential DTI prediction was made, and the obtained samples were sent to the classifier for secondary classification. Results: The performance of Graph-DTI and all baseline methods was evaluated using the sums of the area under the precision-recall curve (AUPR) and the area under the receiver operating characteristic curve (AUC). The results indicated that Graph-DTI outperformed the baseline methods in both performance results. Conclusion: Compared with other baseline DTI prediction methods, the results showed that Graph-DTI had better prediction performance. Additionally, in this study, we effectively classified drugs corresponding to different targets and vice versa. The above findings showed that Graph-DTI provided a powerful tool for drug research, development, and repositioning. Graph- DTI can serve as a drug development and repositioning tool more effectively than previous studies that did not use heterogeneous network graph embedding.

A Heterogeneous Cross Contrastive Learning Method for Drug-Target Interaction Prediction

A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction

Semi-supervised heterogeneous graph contrastive learning for drug-target interaction prediction

Supervised graph co-contrastive learning for drug–target interaction prediction

MPHGCL-DDI: Meta-Path-Based Heterogeneous Graph Contrastive Learning for Drug-Drug Interaction Prediction

Deep graph contrastive learning model for drug-drug interaction prediction

MCL-DTI: Using Drug Multimodal Informationand Bi-directional Cross-Attention Learningmethod for Predicting Drug-Target Interaction

Graph-DTI: A New Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

MSH-DTI: multi-graph convolution with self-supervised embedding and heterogeneous aggregation for drug-target interaction prediction

A knowledge graph-based method for drug-drug interaction prediction with contrastive learning

iGRLDTI: An Improved Graph Representation Learning Method for Predicting Drug-Target Interactions over Heterogeneous Biological Information Network

HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction

CHL-DTI: A Novel High–Low Order Information Convergence Framework for Effective Drug–Target Interaction Prediction

MGACL: Prediction Drug–Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning

Prediction of multi-relational drug-gene interaction via Dynamic hyperGraph Contrastive Learning.

CCL-DTI: contributing the contrastive loss in drug–target interaction prediction

Cross-view contrastive representation learning approach to predicting DTIs via integrating multi-source information

MRGCDDI: Multi-Relation Graph Contrastive Learning without Data Augmentation for Drug-Drug Interaction Events Prediction

Integrating multi-scale neighbouring topologies and cross-modal similarities for drug–protein interaction prediction